Evidence map›Paper›PMID 14662731›Full record

ArticleBritish journal of pharmacology2004

Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.

Kerstin Wirkner, Joana Schweigel, Zoltan Gerevich, Heike Franke, Clemens Allgaier, Edward Leon Barsoumian, Henning Draheim, Peter Illes

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Characterization of Potency of the P2Y13 Receptor Agonists: A Meta-Analysis.International journal of molecular sciences · 2021
    Pooled it
  2. Article
  3. Article
  4. Review
  5. G-protein βγ subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Interaction of P2 purinergic receptors with cellular macromolecules.Naunyn-Schmiedeberg's archives of pharmacology · 2008
    Review
  12. Article
  13. Article
  14. Review
  15. Functions of neuronal P2Y receptors.Pflugers Archiv : European journal of physiology · 2006
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kerstin WirknerRudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Haertelstrasse 16-18, Leipzig D-04107, Germany. wirk@medizin.uni-leipzig.de
Joana Schweigel
Zoltan Gerevich
Heike Franke
Clemens Allgaier
Edward Leon Barsoumian
Henning Draheim
Peter Illes
Leipzig University · DEBoehringer Ingelheim (Germany) · DEBoehringer Ingelheim (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. N-type Ca(2+) channel modulation by an endogenous P2Y receptor was investigated by the whole-cell patch-clamp method in HEK 293 cells transfected with the functional rabbit N-type calcium channel. 2. The current responses (I(Ca(N))) to depolarizing voltage steps were depressed by ATP in a concentration-dependent manner. Inclusion of either guanosine 5'-O-(3-thiodiphosphate) or pertussis toxin into the pipette solution as well as a strongly depolarizing prepulse abolished the inhibitory action of ATP. 3. In order to identify the P2Y receptor subtype responsible for this effect, several preferential agonists and antagonists were studied. Whereas the concentration-response curves of ADP and adenosine 5'-O-(2-thiodiphosphate) indicated a higher potency of these agonists than that of ATP, alpha,beta-methylene ATP, UTP and UDP were considerably less active. The effect of ATP was abolished by the P2Y receptor antagonists suramin and N(6)-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-beta,gamma-dichloromethylene-ATP, but not by pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid, 2'deoxy-N(6)-methyladenosine-3',5'-diphosphate or 2-methylthio AMP. 4. Using reverse transcription and polymerase chain reaction, mRNA for the P2Y(1), P2Y(4), P2Y(6), P2Y(11) and P2Y(13) receptor subtypes, but not the P2Y(2), and P2Y(12) subtypes, was detected in HEK 293 cells. 5. Immunocytochemistry confirmed the presence of P2Y(1), and to a minor extent that of P2Y(4), but not of P2Y(2) receptors. 6. Hence, it is tempting to speculate that P2Y(13) receptors may inhibit N-type Ca(2+) channels via the betagamma subunits of the activated G(i) protein.

Indexed as

Adenine NucleotidesAdenosine DiphosphateAdenosine TriphosphateAnimalsCalcium Channels, N-TypeCalcium SignalingCell LineDose-Response Relationship, DrugGTP-Binding ProteinsHumansMembrane ProteinsPatch-Clamp TechniquesPurinergic P2 Receptor AgonistsPurinergic P2 Receptor AntagonistsRabbitsReceptors, G-Protein-CoupledAdenine Nucleotidesadenosine 5'-O-(1-thiodiphosphate)Adenosine DiphosphateAdenosine TriphosphateCalcium Channels, N-TypeGTP-Binding ProteinsMembrane ProteinsP2RY12 protein, humanP2RY13 protein, humanPurinergic P2 Receptor AgonistsPurinergic P2 Receptor AntagonistsReceptors, G-Protein-CoupledReceptors, Purinergic P2Receptors, Purinergic P2Y12Recombinant ProteinsThionucleotides

Identifiers

PMID14662731
PMCPMC1574174
OpenAlexW2089868086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.